NHPig EU project launches to transform non-clinical research
NHPig EU Project Launches to Transform Non-Clinical Research Lyon, 4/12/2024 --- ETISENSE today announced the launch of NHPig, an EU-funded research project aimed at transforming…
La société ETISENSE célèbre son 6ème anniversaire et inaugure de nouveaux locaux dans le 8ème arrondissement de Lyon !
La société Etisense, pionnier dans le développement de solutions de monitoring physiologique par gilets connectés dans le domaine de la recherche médicale chez l’animal et…
News: DECRO Solution passed GLP qualification at one CRO !
Preclinical safety, pharmacology and toxicology studies are an essential part of drug development, as they help assess the potential safety and toxicity of a candidate-drug…
REPLAY WEBINAR – Marmoset and rat species: how can jacketed telemetry support your non-clinical studies?
Did you miss our webinar? The replay is the opportunity to catch up! ETISENSE and ERBC have jointly organized a webinar on January 30, co-hosted…
Non-Invasive Monitoring Of Cardiac Output: Validation In Anesthetized Laboratory Rats By Pharmacological Beta-Adrenergic Pathway Modulation
Leandro Fontana Pires1,2, Agathe Cambier2, Stéphane Tanguy1, Charles Eynard2, Timothé Flenet2, Pierre-Yves Gumery1, François Boucher1 ¹ PRETA TEAM, TIMC IMAG, 38706 La Tronche CEDEX, France; ² R&D,…
Etisense will attend the Safety Pharmacology Society 2023 Annual Meeting
Visit Etisense at the SPS 2023 Annual Meeting, on September 18-21 at the Square Brussels Meeting Center in Brussels (Belgium), at booth #507. This meeting…